1
Ethiodized Oil-based Transarterial Chemoembolization for Hepatocellular Carcinoma: Randomized Clinical Trial of Anhydrous Cisplatin Suspension versus Cisplatin Emulsion. Yu SCH, Chan L, Lee KF, Cho CCM, Hui EP, Chu CCM, Cheung SYS, Lok HT, Li L, Wong JKT, Wong JC, Yuen TY, Yu PSM, Wong SSM, Wong HL, Ho CHCH, Mo F, Yeo WMM. Radiology. 2025 Nov;317(2):e242982. doi: 10.1148/radiol.242982. PMID: 41288481.
2
Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres Followed by Gemcitabine plus Cisplatin for Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Single-Arm Multicenter Clinical Trial. Chan SL, Chotipanich C, Choo SP, Kwang SW, Mo F, Worakitsitisatorn A, et al. Liver Cancer. 2022 Jun 15;11(5):451-459. doi: 10.1159/000525489. PMID: 36158588; PMCID: PMC9485918.
3
Comparison of Chemoembolization, Radioembolization, and Transarterial Ethanol Ablation for Huge Hepatocellular Carcinoma (≥ 10 cm) in Tumour Response and Long-Term Survival Outcome. Yu SCH, Hui JW, Li L, Cho CC, Hui EP, Chan SL, et al. Cardiovasc Intervent Radiol. 2022 Feb;45(2):172-181. doi: 10.1007/s00270-021-02777-6. Epub 2021 Oct 3. PMID: 34604920.
4
Comparison of Survival Outcomes in Transarterial Ethanol Ablation and Liver Resection for Solitary Hepatocellular Carcinoma ≤ 5 cm in Patients Stratified by Liver Function. Yu SCH, Hui JWY, Chong CCN, Cho CCM, Cheung S, Wong J, et al. Cardiovasc Intervent Radiol. 2022 Mar;45(3):315-327. doi: 10.1007/s00270-021-02768-7. Epub 2021 Oct 5. PMID: 34609579.
5
Transarterial Ethanol Ablation for Small Hepatocellular Carcinoma (≤ 3 cm): A Comparative Study Versus Radiofrequency Ablation. Yu SCH, Hui JWY, Chong CCN, Chu CM, Cheung S, Wong J, et al. Cardiovasc Intervent Radiol. 2020 May;43(5):732-739. doi: 10.1007/s00270-020-02426-4. Epub 2020 Mar 9. PMID: 32152720.